# Safety and Tolerability of Liraglutide in Healthy Male Volunteers

> **NCT01507272** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 34 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** liraglutide
- **DRUG:** liraglutide
- **DRUG:** placebo
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01507272
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** 1999-12
- **Final completion:** 1999-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01507272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01507272, "Safety and Tolerability of Liraglutide in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01507272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*